Rights and permissions
About this article
Cite this article
Pros & cons of disease- and patient-specific outcome measures. Pharmacoecon. Outcomes News 70, 6–7 (1996). https://doi.org/10.1007/BF03270134
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03270134